OXYSEPT 07167X

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a consumer report with the FDA on 2020-01-07 for OXYSEPT 07167X manufactured by Johnson & Johnson Surgical Vision, Inc..

Event Text Entries

[189000205] Age/date of birth: unknown, information not provided. Date of event: date of event: exact date unknown, information not provided. Best estimate is during (b)(6) 2019. (b)(4). All pertinent information available to johnson & johnson surgical vision, inc. Has been submitted.
Patient Sequence No: 1, Text Type: N, H10


[189000206] It was initially reported a consumer used oxysept 1step for a few days and found mold on his lens. The lenses were worn, and afterwards the consumer felt itchy and had more eye discharge than usual. The consumer sought medical attention and was prescribed genderon ophthalmic solution and fluorone. The eye specialist asked to see him again for further examination. The consumer wears extended wear contact lenses. Additional information and clarification were provided, the consumer found there was a dark substance in the bottom of the lens case (the lens case was fresh from the oxysept 1step solution), and suspected it was mold. The contact lenses looked normal, so he wore the lenses regardless, afterwards, he experienced discomfort, irritation, itchiness and eye discharge. He emphasized that he used the solution and the tablet correctly according to the instructions for use (ifu). Through follow-up the patient responded to the question; how long did the lenses soak in neutralized solution before being worn; the consumer could not recall how many days it was after lenses were placed in the solution. The ifu notes that? If you do not intend to wear your lenses immediately after disinfection/neutralization, you may store them in the unopened oxysept cup. Disinfect and neutralize with fresh solution once a week before applying the lenses to your eyes?. The next time the consumer used the lenses (2? 3 days later), the consumer found the dark substance had increased in size, and some was on the lenses, therefore he did not continue to use the lenses. The consumer has not yet gone to get his eyes rechecked. No additional information provided.
Patient Sequence No: 1, Text Type: D, B5


MAUDE Entry Details

Report Number3004178847-2020-00001
MDR Report Key9560214
Report SourceCONSUMER
Date Received2020-01-07
Date of Report2020-02-27
Report Date2005-01-01
Date Reported to FDA2005-01-01
Date Reported to Mfgr2005-01-10
Date Mfgr Received2020-01-30
Date Added to Maude2020-01-07
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional0
Initial Report to FDA0
Report to FDA3
Event Location3
Manufacturer ContactSOMYATA NAGPAL
Manufacturer Street1700 EAST ST. ANDREW PLACE
Manufacturer CitySANTA ANA CA 92705
Manufacturer CountryUS
Manufacturer Postal92705
Manufacturer Phone7142478200
Manufacturer G1JOHNSON & JOHNSON SURGICAL VISION, INC.
Manufacturer Street4TH AVE HZ ECON/TECH DEVELOP. ZONE
Manufacturer CityHANGZHOU 310018
Manufacturer CountryCN
Manufacturer Postal Code310018
Single Use0
Previous Use Code0
Event Type3
Type of Report3

Device Sequence Number: 1

Brand NameOXYSEPT
Generic NameSOLUTIONS
Product CodeLPN
Date Received2020-01-07
Model Number07167X
Lot NumberZD05808
OperatorLAY USER/PATIENT
Device AvailabilityN
Device AgeDA
Device Sequence No1
Device Event Key0
ManufacturerJOHNSON & JOHNSON SURGICAL VISION, INC.
Manufacturer Address1700 E ST ANDREW PLACE SANTA ANA CA 92705 US 92705

Device Sequence Number: 101

Product Code---
Date Received2020-01-07
Device Sequence No101
Device Event Key0


Patients

Patient NumberTreatmentOutcomeDate
101. Required No Informationntervention 2020-01-07

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.